About
Strategy
Portfolio
Team
News
Get in touch
0%
Location Geleen, Netherlands
Investment year 2012
Acquired by Fresenius Kabi
Health
Exited

EnzyPep

Enzymatic peptide synthesis technology for pharmaceutical manufacturing.